1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow NAFLD: new trials by email Literature Review of NAFLD trials Research Report on NAFLD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rifaximin in Fatty Liver Disease Rifaximin - Nonalcoholic Fatty Liver Disease, NAFLD | Phase 4 | Terminated | Imperial College London | 15 | 2011-05-01 | 2020-10-28 |
Inflammation (1) · Insulin Resistance (1) · Non-alcoholic Fatty Liver Disease (1)
Digestive System Diseases (1) · Fatty Liver (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Liver Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Rifaximin (1)
United Kingdom (1)
Jeremy FL Cobbold, PhD (1) · Mark R Thursz, MD (1)